Clinical trial
Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression
NCT07672431
Study timeline
Study start (estimated)2026-09-01Date precision: month
Registry last updated2026-06-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Triple Negative Breast Cancerunresolved
Interventions
TheraBionic P1DEVICE
Sponsors & collaborators
Barbara Ann Karmanos Cancer Institutelead sponsor
THERABIONIC INC.collaborator
Ucancervivecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07672431 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.